Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

For How Much Longer Is Your CE Marking Valid? The MDR Transition Arrangements

This article was originally published in Clinica

Executive Summary

The point at which medtech companies must stop CE marking their products under the current three EU medical device directives remains unclear, despite the significant time-consuming and costly adjustments industry will need to make to become compliant with the future Medical Device and IVD Regulations.

You may also be interested in...



EU Device Regulation: More Clarity On Transition Period, Existing CE-Marking Validity

There has been some confusion about how long companies will have before their devices must comply to the pending Medical Devices Regulation in Europe. Details discovered by Medtech Insight about the likely final version of the text, due to be published next week, may provide a clearer picture of what lies ahead.

EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency

Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.

First Public Discussion On How EU Medtech Regulatory Governance Structure May Evolve

Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadly agreed that change is now critical.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT040833

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel